BACKGROUND: Previous thoracic artificial lungs (TALs) had blood flow impedance greater than that of the natural lungs, which could cause abnormal pulmonary hemodynamics. New compliant TALs (cTALs), however, have an impedance lower than that of the natural lung. METHODS: In this study, a cTAL of new design was attached between the pulmonary artery (PA) and the left atrium (LA) in 5 sheep (60.2 ± 1.9 kg). A distal PA band was placed to control the percentage of cardiac output (CO) routed to the cTAL. Rest and exercise conditions were simulated using a continuous dobutamine infusion of 0 and 5 μg/kg/min, respectively. At each dose, a hemodynamic data set was acquired at baseline (no flow to the cTAL), and 60%, 75%, and 90% of CO was shunted to the cTAL. RESULTS: Device resistance did not vary with blood flow rate, averaging 0.51 ± 0.03 mm Hg/(L/min). Under all conditions, CO was not significantly different from baseline. Pulmonary system impedance increased above baseline only with 5 μg/kg/min of dobutamine and 90% of CO diverted to the cTAL. CONCLUSIONS: Results indicated minimal changes in pulmonary hemodynamics during PA-LA cTAL attachment for high device flows under rest and exercise conditions.
BACKGROUND: Previous thoracic artificial lungs (TALs) had blood flow impedance greater than that of the natural lungs, which could cause abnormal pulmonary hemodynamics. New compliant TALs (cTALs), however, have an impedance lower than that of the natural lung. METHODS: In this study, a cTAL of new design was attached between the pulmonary artery (PA) and the left atrium (LA) in 5 sheep (60.2 ± 1.9 kg). A distal PA band was placed to control the percentage of cardiac output (CO) routed to the cTAL. Rest and exercise conditions were simulated using a continuous dobutamine infusion of 0 and 5 μg/kg/min, respectively. At each dose, a hemodynamic data set was acquired at baseline (no flow to the cTAL), and 60%, 75%, and 90% of CO was shunted to the cTAL. RESULTS: Device resistance did not vary with blood flow rate, averaging 0.51 ± 0.03 mm Hg/(L/min). Under all conditions, CO was not significantly different from baseline. Pulmonary system impedance increased above baseline only with 5 μg/kg/min of dobutamine and 90% of CO diverted to the cTAL. CONCLUSIONS: Results indicated minimal changes in pulmonary hemodynamics during PA-LA cTAL attachment for high device flows under rest and exercise conditions.
Authors: Keith E Cook; Carrie E Perlman; Ralf Seipelt; Carl L Backer; Constantine Mavroudis; Lyle F Mockrost Journal: ASAIO J Date: 2005 Jul-Aug Impact factor: 2.872
Authors: Hitoshi Sato; John W McGillicuddy; Grant W Griffith; Amy M Cosnowski; Sean D Chambers; Ronald B Hirschl; Robert H Bartlett; Keith E Cook Journal: ASAIO J Date: 2006 May-Jun Impact factor: 2.872
Authors: Begum Akay; Junewai L Reoma; Daniele Camboni; Joshua R Pohlmann; John M Albert; Ayushi Kawatra; Ayanna D Gouch; Robert H Bartlett; Keith E Cook Journal: Ann Thorac Surg Date: 2010-07 Impact factor: 4.330
Authors: Y Takewa; E Tatsumi; Y Taenaka; K Eya; T Nakatani; T Nishimura; Y S Sohn; T Masuzawa; Y Wakisaka; M Nakamura; S Endo; H Takano; S Kitamura Journal: ASAIO J Date: 1997 Sep-Oct Impact factor: 2.872
Authors: T Müller; M Lubnow; A Philipp; T Bein; A Jeron; A Luchner; L Rupprecht; M Reng; J Langgartner; C E Wrede; M Zimmermann; D Birnbaum; C Schmid; G A J Riegger; M Pfeifer Journal: Eur Respir J Date: 2008-11-14 Impact factor: 16.671
Authors: Begum Akay; Julie A Foucher; Daniele Camboni; Kelly L Koch; Ayushi Kawatra; Keith E Cook Journal: ASAIO J Date: 2012 Jul-Aug Impact factor: 2.872
Authors: David J Skoog; Joshua R Pohlmann; David S Demos; Christopher N Scipione; Amit Iyengar; Rebecca E Schewe; Ahmed B Suhaib; Kelly L Koch; Keith E Cook Journal: ASAIO J Date: 2017 Sep/Oct Impact factor: 2.872
Authors: Benjamin D Carr; Clinton J Poling; Pavel Hala; Matias Caceres Quinones; Aaron R Prater; Jennifer S McLeod; Robert H Bartlett; Alvaro Rojas-Pena; Ronald B Hirschl Journal: ASAIO J Date: 2020-05 Impact factor: 3.826